179 related articles for article (PubMed ID: 37726305)
1. Opiorphin as a biomarker of orofacial conditions: a meta-analysis.
Porporatti AL; de Oliveira Machado CA; Alajbeg I; Alajbeg IZ; Paszynska E; Dmitrzak-Weglarz M; Braud A; Boucher Y
Sci Rep; 2023 Sep; 13(1):15533. PubMed ID: 37726305
[TBL] [Abstract][Full Text] [Related]
2. Time-course of pain and salivary opiorphin release in response to oral capsaicin differ in burning mouth syndrome patients, temporomandibular disorders patients and control subjects.
Alajbeg IZ; Vrbanovic E; Alajbeg I; Orabovic I; Naka K; Mrla A; Boucher Y
Clin Oral Investig; 2024 Apr; 28(5):246. PubMed ID: 38589630
[TBL] [Abstract][Full Text] [Related]
3. Salivary opiorphin in dental pain: A potential biomarker for dental disease.
Ozdogan MS; Gungormus M; Ince Yusufoglu S; Ertem SY; Sonmez C; Orhan M
Arch Oral Biol; 2019 Mar; 99():15-21. PubMed ID: 30590229
[TBL] [Abstract][Full Text] [Related]
4. Opiorphin in burning mouth syndrome patients: a case-control study.
Salarić I; Sabalić M; Alajbeg I
Clin Oral Investig; 2017 Sep; 21(7):2363-2370. PubMed ID: 28013436
[TBL] [Abstract][Full Text] [Related]
5. Expression of salivary immunoglobulins and their association with analgesic neuropeptide opiorphin in anorexia nervosa during adolescence.
Paszynska E; Hernik A; Slopien A; Boucher Y; Tyszkiewicz-Nwafor M; Roszak M; Bilska K; Dmitrzak-Weglarz M
J Eat Disord; 2022 Aug; 10(1):118. PubMed ID: 35953876
[TBL] [Abstract][Full Text] [Related]
6. Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study.
Boucher Y; Braud A; Dufour E; Agbo-Godeau S; Baaroun V; Descroix V; Guinnepain MT; Ungeheuer MN; Ottone C; Rougeot C
Clin Oral Investig; 2017 Sep; 21(7):2157-2164. PubMed ID: 27834029
[TBL] [Abstract][Full Text] [Related]
7. A study of salivary opiorphin levels using different anesthetic drugs and techniques - A randomized controlled clinical study.
Parida SK; Guruprasad T; Krishnakumar VB; Ravi RP
J Stomatol Oral Maxillofac Surg; 2018 Jun; 119(3):169-171. PubMed ID: 29247820
[TBL] [Abstract][Full Text] [Related]
8. Salivary opiorphin levels in denture-related traumatic ulcers.
Ozdogan MS; Gungormus M
Oral Dis; 2023 Oct; ():. PubMed ID: 37793134
[TBL] [Abstract][Full Text] [Related]
9. Tear Opiorphin Levels in Ocular Pain Caused by Corneal Foreign Body.
Ozdogan S; Sonmez C; Yolcu D; Gungormus M
Cornea; 2020 Nov; 39(11):1377-1380. PubMed ID: 32482963
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Salivary Opiorphin, pH and Flow Rate in Oral Submucous Fibrosis - A Case - Control Observational Study.
Varsha KS; Lakshmi KC; Ganesan A; Kannan A; Aniyan KY
J Pharm Bioallied Sci; 2023 Jul; 15(Suppl 1):S656-S660. PubMed ID: 37654371
[TBL] [Abstract][Full Text] [Related]
11. Is there a link between stress and immune biomarkers and salivary opiorphin in patients with a restrictive-type of anorexia nervosa?
Paszynska E; Roszak M; Slopien A; Boucher Y; Dutkiewicz A; Tyszkiewicz-Nwafor M; Gawriolek M; Otulakowska-Skrzynska J; Rzatowski S; Dmitrzak-Weglarz M
World J Biol Psychiatry; 2020 Mar; 21(3):220-229. PubMed ID: 30880537
[No Abstract] [Full Text] [Related]
12. Is burning mouth syndrome associated with stress? A meta-analysis.
Porporatti AL; Schroder ÂGD; Lebel A; Moreau N; Misery L; Alajbeg I; Braud A; Boucher Y
J Oral Rehabil; 2023 Nov; 50(11):1279-1315. PubMed ID: 37332081
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Salivary opiorphin levels in anorexia nervosa: A case-control study.
Paszynska E; Dmitrzak-Weglarz M; Roszak M; Boucher Y; Dutkiewicz A; Tyszkiewicz-Nwafor M; Gawriolek M; Otulakowska-Skrzynska J; Rzatowski S; Slopien A
World J Biol Psychiatry; 2020 Mar; 21(3):212-219. PubMed ID: 30179071
[No Abstract] [Full Text] [Related]
15. Relationship between saliva opiorphin levels, pain threshold, and cutting number in adolescents with non suicidal self injury.
Gavcar EG; Kabukçu Başay B; Avci E; Başay Ö
J Psychiatr Res; 2022 Jul; 151():611-618. PubMed ID: 35636040
[TBL] [Abstract][Full Text] [Related]
16. Comparison of electroencephalographic changes in response to acute electrical and thermal stimuli with the tail flick and hot plate test in rats administered with opiorphin.
Singh P; Kongara K; Harding D; Ward N; Dukkipati VSR; Johnson C; Chambers P
BMC Neurol; 2018 Apr; 18(1):43. PubMed ID: 29673329
[TBL] [Abstract][Full Text] [Related]
17. Acute Dental Pain and Salivary Biomarkers for Stress and Inflammation in Patients with Pulpal or Periapical Inflammation.
Haug SR; Marthinussen MC
J Oral Facial Pain Headache; 2019; 33(2):227–233. PubMed ID: 30304079
[TBL] [Abstract][Full Text] [Related]
18. Systemically active human opiorphin is a potent yet non-addictive analgesic without drug tolerance effects.
Rougeot C; Robert F; Menz L; Bisson JF; Messaoudi M
J Physiol Pharmacol; 2010 Aug; 61(4):483-90. PubMed ID: 20814077
[TBL] [Abstract][Full Text] [Related]
19. Systemic antibiotics for symptomatic apical periodontitis and acute apical abscess in adults.
Cope A; Francis N; Wood F; Mann MK; Chestnutt IG
Cochrane Database Syst Rev; 2014 Jun; (6):CD010136. PubMed ID: 24967571
[TBL] [Abstract][Full Text] [Related]
20. STR-324, a Stable Analog of Opiorphin, Causes Analgesia in Postoperative Pain by Activating Endogenous Opioid Receptor-dependent Pathways.
Sitbon P; Van Elstraete A; Hamdi L; Juarez-Perez V; Mazoit JX; Benhamou D; Rougeot C
Anesthesiology; 2016 Nov; 125(5):1017-1029. PubMed ID: 27571257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
